Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) reported Return on Capital Employed [ROCE] of 10.74% for Q2 2026, down 0.48 percentage points from 11.23% a year earlier but up 0.55 percentage points from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals posted Return on Capital Employed [ROCE] of 10.28%, down 2.39 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -16.63 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at 12.68% in FY2024 (-1.92 pp), 14.60% in FY2023 (-5.00 pp), 19.60% in FY2022 (-31.92 pp) and 51.52% in FY2021 (+24.60 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of 9.94% in Q4 2025 and a high of 43.39% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last 17 quarters, with an average year-over-year change of -1.58 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2021 (a gain of 17.71 percentage points); the low point was Q4 2022 (a drop of 24.66 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 10.19% (Q1 2026), 9.94% (Q4 2025) and 10.61% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 17.83%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 17.92%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 19.32%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 16.76%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -5.97%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 11.86%
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 10.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.74%
Mar 31, 2026 10.19%
Dec 31, 2025 9.94%
Sep 30, 2025 10.61%
Jun 30, 2025 11.23%
Mar 31, 2025 11.24%
Dec 31, 2024 11.86%
Sep 30, 2024 12.00%
Jun 30, 2024 12.31%
Mar 31, 2024 12.78%
Dec 31, 2023 13.86%
Sep 30, 2023 15.18%
Jun 30, 2023 15.90%
Mar 31, 2023 16.68%
Dec 31, 2022 18.73%
Sep 30, 2022 25.37%
Jun 30, 2022 28.87%
Mar 31, 2022 39.73%
Dec 31, 2021 43.39%
Sep 30, 2021 39.62%
API Access

Regeneron Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=REGN&period=max&api_key=YOUR_API_KEY